Leaders from Meningitis Now and the Meningitis Research Foundation, two U.K. charities dedicated to fighting meningitis, recently said they intend to encourage Petitions and Health committees to accept an action plan against meningitis B.
The two charities will do so at the second of its two evidence sessions. The sessions have been brought about with a petition that more than 820,000 people have signed. The petition, if approved, will widen the vaccination for meningococcal group B (Men B).
The new, time-based action plan could help the U.K. government provide additional protection to families against the dangerous illness.
“Too many children are still being killed and seriously disabled by what is a vaccine preventable disease,” Vinny Smith, chief executive at Meningitis Research Foundation, said. “The parliamentary debate, bought about by the overwhelming response to the petition to extend MenB vaccination, gives us a unique opportunity to help end the dreadful suffering caused to families in the U.K. by Men B. Along with Meningitis Now, Meningitis Research Foundation urges the government to make better protection from Men B a reality as soon as possible.”
So far, government officials have stated that it is too costly to expand the vaccination program.
“The sad death of Faye Burdett and the overwhelming response across the U.K., has given the government a unique opportunity to reappraise some of the outstanding issues around the Men B immunization program,” Meningitis Now Chief Executive Sue Davie said. “I would recommend that they grab this opportunity and work with both Meningitis Now and the Meningitis Research Foundation, to formulate a program and plan that delivers on the demands of the hundreds of thousands of people who signed the petition and that is simply to protect our children.”